home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Responding To Sepsis

 
  November, 1 2007 1:35
your information resource in human molecular genetics
 
     
How quickly key receptors are activated on blood vessel cells can determine whether one survives or succumbs to sepsis, suggests a report online in Nature Immunology.

Sepsis, a potentially life-threatening immune response to blood-borne infections, leads to loss of blood vessel function, resulting in shock and multiorgan failure. Athan Kuliopulos and colleagues looked to see if inhibition or activation of a receptor called PAR1 could limit the severity of sepsis. Mice injected with bacteria directly into the bloodstream developed sepsis and died; however, these mice were protected if given a PAR1 inhibitor within 4 hours.

The surprise came if PAR1 was inhibited at later times, as this failed to protect these mice; rather, activation of PAR1 at these later times 'protected' mice from toxic shock. The authors show this 'late' activation of PAR1 induces another PAR receptor to become activated. This establishes a protective effect by instructing cells lining the blood vessel to maintain tight junctions and averting the widespread edema and intravascular blood clotting that accompanies shock.

These findings might lead to successful therapies for patients with sepsis and other systemic inflammatory responses.

Author contact:

Athan Kuliopulos (Tufts-New England Medical Center, Boston, MA, USA)
E-mail: athan.kuliopulos@tufts.edu

Abstract available online.

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.